US FDA biosimilars guidelines expected soon
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration reportedly will soon release its much-anticipated regulatory guidelines for makers of biosimilars, although an FDA spokeswoman on 23 September declined to confirm an exact date1,2.